<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2011-7582</journal-id>
<journal-title><![CDATA[Revista Colombiana de Cirugía]]></journal-title>
<abbrev-journal-title><![CDATA[rev. colomb. cir.]]></abbrev-journal-title>
<issn>2011-7582</issn>
<publisher>
<publisher-name><![CDATA[Asociación Colombiana de Cirugía]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2011-75822025000200364</article-id>
<article-id pub-id-type="doi">10.30944/20117582.2666</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Biomarcadores clásicos y nuevos como predictores potenciales en patología biliar y coledocolitiasis. Revisión sistemática]]></article-title>
<article-title xml:lang="en"><![CDATA[Classic and novel biomarkers as potential predictors in biliary pathology and choledocholithiasis. Systematic review]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ortega-Erazo]]></surname>
<given-names><![CDATA[Juan Pablo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pino]]></surname>
<given-names><![CDATA[Luis Fernando]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sauza]]></surname>
<given-names><![CDATA[Frank]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Acosta]]></surname>
<given-names><![CDATA[Naydu]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Triana]]></surname>
<given-names><![CDATA[Luz Elena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Libre Facultad de Salud ]]></institution>
<addr-line><![CDATA[Cali ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2025</year>
</pub-date>
<volume>40</volume>
<numero>2</numero>
<fpage>364</fpage>
<lpage>377</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S2011-75822025000200364&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S2011-75822025000200364&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S2011-75822025000200364&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción.  La colelitiasis es una afección común en las poblaciones occidentales, con una alta prevalencia en Colombia, que obliga a un número considerable de cirugías anualmente. Algunos factores como la saturación de colesterol en la bilis y la hipomotilidad de la vesícula biliar contribuyen a la formación de los cálculos. Los métodos de diagnóstico tradicionales se complementan con indicadores, como el antecedente de pancreatitis biliar. El objetivo de este trabajo fue evaluar la eficacia de los biomarcadores para hacer el diagnóstico y establecer un pronóstico de la patología biliar.  Métodos.  Se estableció una pregunta de investigación y se desarrolló una ecuación de búsqueda específica siguiendo las directrices PRISMA para la selección de estudios relevantes.  Resultados.  Se identificaron varios biomarcadores prometedores, incluyendo ácidos grasos, enzimas hepáticas, oligoelementos, lisofosfatidilcolina, ácidos grasos libres y Ca 19-9, junto con la eficacia de los biomarcadores clásicos en el diagnóstico de coledocolitiasis, como la bilirrubina total y la PCR.  Conclusión.  Los oligoelementos, en particular hierro, calcio y zinc, muestran un potencial significativo para mejorar el diagnóstico de la patología biliar, incluida la coledocolitiasis, debido a su asociación fisiopatológica directa, la alta sensibilidad y especificidad comparables o incluso superiores a los biomarcadores clásicos, su complementariedad con estos últimos, la capacidad de detección temprana y la accesibilidad en la práctica clínica. Sin embargo, se requiere más investigación para validar su uso clínico en estos contextos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction.  Cholelithiasis is a common condition in Western populations, with a high prevalence in Colombia, which requires a considerable number of surgeries annually. Some factors, such as cholesterol saturation in the bile and gallbladder hypomotility contribute to stone formation. Traditional diagnostic methods are complemented by indicators, such as a history of biliary pancreatitis. The objective of this study was to evaluate the effectiveness of biomarkers to make the diagnosis and establish a prognosis of biliary pathology.  Methods.  A research question was established and a specific search equation was developed following PRISMA guidelines for the selection of relevant studies.  Results.  Several promising biomarkers were identified, including fatty acids, liver enzymes, trace elements, lysophosphatidylcholine, free fatty acids, and Ca 19-9, along with the efficacy of classical biomarkers in the diagnosis of choledocholithiasis, such as total bilirubin and PCR.  Conclusion.  Trace elements, in particular iron, calcium, and zinc, show significant potential to improve the diagnosis of biliary pathology, including choledocholithiasis, due to their direct pathophysiological association, high sensitivity and specificity comparable to or even superior to classic biomarkers, their complementarity with the latter, the capacity for early detection and accessibility in clinical practice. However, more research is required to validate their clinical use in these contexts.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[cálculos biliares]]></kwd>
<kwd lng="es"><![CDATA[colelitiasis]]></kwd>
<kwd lng="es"><![CDATA[coledocolitiasis]]></kwd>
<kwd lng="es"><![CDATA[biomarcadores]]></kwd>
<kwd lng="es"><![CDATA[diagnóstico]]></kwd>
<kwd lng="es"><![CDATA[pronóstico]]></kwd>
<kwd lng="en"><![CDATA[gallstones]]></kwd>
<kwd lng="en"><![CDATA[cholelithiasis]]></kwd>
<kwd lng="en"><![CDATA[choledocholithiasis]]></kwd>
<kwd lng="en"><![CDATA[biomarkers]]></kwd>
<kwd lng="en"><![CDATA[diagnostic]]></kwd>
<kwd lng="en"><![CDATA[prognosis]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zarate]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Torrealba]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Patiño]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Raue]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Colelitiasis]]></article-title>
<source><![CDATA[Manual de enfermedades digestivas quirúrgicas]]></source>
<year>2018</year>
<page-range>1-6</page-range><publisher-name><![CDATA[Universidad Finis Terrae - Escuela de Medicina]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laura-Sandoval]]></surname>
<given-names><![CDATA[KE]]></given-names>
</name>
<name>
<surname><![CDATA[Mandarachi-Flores]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
</person-group>
<source><![CDATA[Utilidad del PCR y marcadores inflamatorios como indicadores de colecistitis aguda en pacientes del servicio de cirugía general en el Hospital Militar Central, 2021]]></source>
<year>2024</year>
<publisher-name><![CDATA[Repositorio Universidad Nacional del Centro del Perú]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaitán]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[VM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad litiásica biliar, experiencia en una clínica de cuarto nivel, 2005-2011]]></article-title>
<source><![CDATA[Rev Colomb Cir.]]></source>
<year>2014</year>
<volume>29</volume>
<page-range>188-96</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ureña]]></surname>
<given-names><![CDATA[SY]]></given-names>
</name>
<name>
<surname><![CDATA[Salazar-Muente]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Barriga-Briceño]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Vera-Calderón]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Suárez-Arellano]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cálculos complejos o difíciles en la endoscopia de vía biliar (CPRE): dilatación con balones de gran diámetro y otros métodos de manejo. Experiencia acumulada en un centro endoscópico de referencia 2009-2018]]></article-title>
<source><![CDATA[Rev Gastroenterol Perú.]]></source>
<year>2021</year>
<volume>41</volume>
<page-range>94-102</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ye]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lyu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The predictive value of different laboratory indicators based on the 2018 Tokyo guidelines for the severity of acute cholangitis]]></article-title>
<source><![CDATA[J Emerg Med.]]></source>
<year>2023</year>
<volume>65</volume>
<page-range>e280-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quiroga-Meriño]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[Estrada-Brizuela]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Méndez-León]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández-Agüero]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Valor de la colangiografía transcística videolaparoscópica en pacientes con sospecha de coledocolitiasis]]></article-title>
<source><![CDATA[Rev Arch Med Camagüey.]]></source>
<year>2020</year>
<volume>24</volume>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Page]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[McKenzie]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Bossuyt]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Boutron]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Hoffmann]]></surname>
<given-names><![CDATA[TC]]></given-names>
</name>
<name>
<surname><![CDATA[Mulrow]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The PRISMA 2020 statement: An updated guideline for reporting systematic reviews]]></article-title>
<source><![CDATA[BMJ.]]></source>
<year>2021</year>
<volume>372</volume>
<page-range>n71</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gong]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Feng]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Mei]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Niu]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Plasma metabolomics and proteomics reveal novel molecular insights and biomarker panel for cholelithiasis]]></article-title>
<source><![CDATA[J Pharm Biomed Anal.]]></source>
<year>2024</year>
<volume>238</volume>
<page-range>115806</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nuñez-Sam]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Eficacia de la gammaglutamil transpeptidasa y fosfatasa alcalina como biomarcador predictor de coledocolitiasis en pacientes atendidos en el Hospital de Vitarte. Periodo enero - diciembre 2019]]></source>
<year>2020</year>
<publisher-name><![CDATA[Repositorio Universidad Privada San Juan Bautista]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valentín-Gamazo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Maderuelo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Salanova]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Aguado]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Suero]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[¿Sospecho coledocolitiasis? Valor de la bilirrubina total al ingreso como predictor único de coledocolitiasis]]></article-title>
<source><![CDATA[Revista Acircal.]]></source>
<year>2022</year>
<volume>9</volume>
<page-range>1-14</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guzmán-Julca]]></surname>
<given-names><![CDATA[AO]]></given-names>
</name>
<name>
<surname><![CDATA[Monzón-Ascencio]]></surname>
<given-names><![CDATA[ET]]></given-names>
</name>
</person-group>
<source><![CDATA[Valor diagnóstico de gammaglutamil-transferasa y fosfatasa alcalina como predictor de coledocolitiasis secundaria a colelitiasis]]></source>
<year>2024</year>
<publisher-name><![CDATA[Universidad Nacional de Trujillo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferkingstad]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sulem]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Atlason]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Sveinbjornsson]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Magnusson]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Styrmisdottir]]></surname>
<given-names><![CDATA[EL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Large-scale integration of the plasma proteome with genetics and disease]]></article-title>
<source><![CDATA[Nat Genet.]]></source>
<year>2021</year>
<volume>53</volume>
<page-range>1712-21</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pietzner]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wheeler]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Carrasco-Zanini]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cortes]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Koprulu]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wörheide]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mapping the proteo-genomic convergence of human diseases]]></article-title>
<source><![CDATA[Science.]]></source>
<year>2021</year>
<volume>374</volume>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Cui]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Features of metabolite changes in disease evolution in cholecystolithiasis]]></article-title>
<source><![CDATA[Dig Dis Sci.]]></source>
<year>2024</year>
<volume>69</volume>
<page-range>275-88</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Japer]]></surname>
<given-names><![CDATA[FM]]></given-names>
</name>
<name>
<surname><![CDATA[Mohammed]]></surname>
<given-names><![CDATA[NY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Investigation study for some trace elements and biliary biomarkers in the cholelithiasis patients]]></article-title>
<source><![CDATA[Adv Res J Med Clin Sci.]]></source>
<year>2023</year>
<volume>9</volume>
<page-range>1227-36</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Byun]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Shim]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Oh]]></surname>
<given-names><![CDATA[YK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis]]></article-title>
<source><![CDATA[Nat Commun.]]></source>
<year>2022</year>
<volume>13</volume>
<page-range>1516</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gu]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Tong]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum carbohydrate antigen 199 as a biomarker for evaluating patients with choledocholithiasis]]></article-title>
<source><![CDATA[Gastroenterol Res Pract.]]></source>
<year>2020</year>
<volume>2020</volume>
<page-range>2739612</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barbhuiya]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Sahasrabuddhe]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
<name>
<surname><![CDATA[Pinto]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Muthusamy]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[TD]]></given-names>
</name>
<name>
<surname><![CDATA[Nanjappa]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comprehensive proteomic analysis of human bile]]></article-title>
<source><![CDATA[Proteomics.]]></source>
<year>2011</year>
<volume>11</volume>
<page-range>4443-53</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[MZ]]></given-names>
</name>
<name>
<surname><![CDATA[Xie]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[XC]]></given-names>
</name>
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[ZH]]></given-names>
</name>
<name>
<surname><![CDATA[Qian]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ma]]></surname>
<given-names><![CDATA[ZH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of biliary protein spectrum in gallstone patients with obesity and those with normal body weight]]></article-title>
<source><![CDATA[Hepatobiliary Pancreat Dis Int.]]></source>
<year>2024</year>
<volume>23</volume>
<page-range>385-92</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
